The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Amelin A.V.

Pavlov First Saint Petersburg State Medical University

Afanasyev V.V.

Evdokimov Moscow State University of Medicine and Dentistry

Barantsevich E.R.

Pavlov First Saint Petersburg State Medical University

Burd S.G.

Pirogov Russian National Research Medical University;
Federal center of brain research and neurotechnologies

Grigolashvili M.A.

Medical University of Karaganda

Davydov O.S.

Research Institute of General Pathology and Pathophysiology

Danilov A.B.

Sechenov First Moscow State Medical University (Sechenov University)

Zharkinbekova N.A.

South Kazakhstan medical academy

Iskra D.A.

Saint Petersburg State Pediatric Medical University

Kukushkin M.L.

Research Institute of General Pathology and Pathophysiology

Naumov A.V.

Pirogov Russian National Research Medical University

Nurguzhaev E.S.

Sanzhar Asfendiyarov Kazakh national medical University

Rachin A.P.

National Research Medical Center for Rehabilitation and Balneology

Churyukanov M.V.

Sechenov First Moscow State Medical University (Sechenov University);
Petrovsky National Research Centre of Surgery

Yakupov E.Z.

Scientific Research Medical Complex «Your Health»;
Kazan State Medical University

Pyrimidine nucleotides in pain management. Consensus of the international group of specialists

Authors:

Amelin A.V., Afanasyev V.V., Barantsevich E.R., Burd S.G., Grigolashvili M.A., Davydov O.S., Danilov A.B., Zharkinbekova N.A., Iskra D.A., Kukushkin M.L., Naumov A.V., Nurguzhaev E.S., Rachin A.P., Churyukanov M.V., Yakupov E.Z.

More about the authors

Journal: Russian Journal of Pain. 2023;21(1): 78‑84

DOI: 10.17116/pain20232101178

Read: 4274 times

Download PDF (RU)
Contact the author
Table of contents

PYRIMIDINE NUCLEOTIDES IN PAIN MANAGEMENT. CONSENSUS OF THE INTERNATIONAL GROUP OF SPECIALISTS
PYRIMIDINE NUCLEOTIDES IN PAIN MANAGEMENT. CONSENSUS OF THE INTERNATIONAL GROUP OF SPECIALISTS

To cite this article:

Amelin AV, Afanasyev VV, Barantsevich ER, et al. . Pyrimidine nucleotides in pain management. Consensus of the international group of specialists. Russian Journal of Pain. 2023;21(1):78‑84. (In Russ.)
https://doi.org/10.17116/pain20232101178

Подписка 2025 Российский журнал боли (Russian Journal of Pain)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Pyrimidine nucleotides in pain management. Consensus of the international group of specialists.

Authors:

Amelin A.V.

Pavlov First Saint Petersburg State Medical University

Afanasyev V.V.

Evdokimov Moscow State University of Medicine and Dentistry

Barantsevich E.R.

Pavlov First Saint Petersburg State Medical University

Burd S.G.

Pirogov Russian National Research Medical University;
Federal center of brain research and neurotechnologies

Grigolashvili M.A.

Medical University of Karaganda

Davydov O.S.

Research Institute of General Pathology and Pathophysiology

Danilov A.B.

Sechenov First Moscow State Medical University (Sechenov University)

Zharkinbekova N.A.

South Kazakhstan medical academy

Iskra D.A.

Saint Petersburg State Pediatric Medical University

Kukushkin M.L.

Research Institute of General Pathology and Pathophysiology

Naumov A.V.

Pirogov Russian National Research Medical University

Nurguzhaev E.S.

Sanzhar Asfendiyarov Kazakh national medical University

Rachin A.P.

National Research Medical Center for Rehabilitation and Balneology

Churyukanov M.V.

Sechenov First Moscow State Medical University (Sechenov University);
Petrovsky National Research Centre of Surgery

Yakupov E.Z.

Scientific Research Medical Complex «Your Health»;
Kazan State Medical University

Received:

28.12.2022

Accepted:

09.01.2023

Close metadata

References:

  1. Davydov OS. The prevalence of pain syndromes and their impact on the quality of life in the world and in Russia, according to a global burden of disease research for the period from 1990 to 2013. Russian Journal of Pain. 2015;3-4:11-18. (In Russ.).
  2. Yakhno NN, Kukushkin ML, Churyukanov MV, Syrovegin AV. The results of open multicenter study MERIDIAN to assess the prevalence of pain syndromes in outpatient practice and therapeutic preferences of doctors. Russian Journal of Pain. 2012;3-4(36-37):10-14. (In Russ.).
  3. Walsh NE, Brooks P, Hazes JM, Walsh RM, Dreinhöfer K, Woolf AD, Akesson K, Lidgren L; Bone and Joint Decade Task Force for Standards of Care for Acute and Chronic Musculoskeletal Pain. Standards of care for acute and chronic musculoskeletal pain: the Bone and Joint Decade (2000—2010). Arch Phys Med Rehabil. 2008;89(9):1830-1845. PMID: 1876017  https://doi.org/10.1016/j.apmr.2008.04.009
  4. Yakhno NN, Kukushkin ML. Chronic pain: medico-biologic and sotsio-economic aspects. Vestnik Rossiiskoi akademii meditsinskikh nauk — Annals of the Russian Academy of Medical Sciences. 2012;9:54-58. 
  5. Gureje O, Simon GE, Von Korff M. A cross-national study of the course of persistent pain in primary care. Pain. 2001;92(1-2):195-200. 
  6. Unpublished data. «Study of Chronic Pain», report on the results of a survey of Russian adults (18+), All-Russian Center for the Study of Public Opinion, Moscow, 2021, commissioned by the Russian Society for the Study of Pain. (In Russ.).
  7. Nasonov EL, Yakhno NN, Karateev AE, Alekseeva LI, Barinov AN, Barulin AE, Davydov OS, Danilov AB, Zhuravleva MV, Zavodovsky BV, Kopenkin SS, Kukishkin ML, Parfenov VA, Strakhov MA, Tyurin VP, Chichasova NV, Chorbinskaya SA. General principles of treatment for musculoskeletal pain: interdisciplinary consensus. Rheumatology Science and Practice. 2016;54(3):247-265. (In Russ.). https://doi.org/10.14412/1995-4484-2016-247-265
  8. Itz CJ, Geurts JW, van Kleef M, Nelemans P. Clinical course of non-specific low back pain: a systematic review of prospective cohort studies set in primary care. Eur J Pain. 2013;17(1):5-15. Epub 2012 May 28. PMID: 22641374. https://doi.org/10.1002/j.1532-2149.2012.00170.x
  9. Chen Y, Campbell P, Strauss VY, Foster NE, Jordan KP, Dunn KM. Trajectories and predictors of the long-term course of low back pain: cohort study with 5-year follow-up. Pain. 2018;159(2):252-260. PMID: 29112007; PMCID: PMC5771685. https://doi.org/10.1097/j.pain.0000000000001097
  10. Karateev AE, Nasonov EL, Ivashkin VT, et al. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Rheumatology Science and Practice. 2018;56(suppl 1):1-29 (In Russ.). https://doi.org/10.14412/1995-4484-2018-1-29
  11. de Campos TF. Low back pain and sciatica in over 16s: assessment and management NICE Guideline [NG59]. J Physiother. 2017;63(2):120. Epub 2017 Mar 7. PMID: 28325480. https://doi.org/10.1016/j.jphys.2017.02.012
  12. Chou R, Deyo R, Friedly J, Skelly A, Weimer M, Fu R, Dana T, Kraegel P, Griffin J, Grusing S. Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166(7):480-492. Epub 2017 Feb 14. PMID: 28192790. https://doi.org/10.7326/M16-2458
  13. Cashin AG, Folly T, Bagg MK, Wewege MA, Jones MD, Ferraro MC, Leake HB, Rizzo RRN, Schabrun SM, Gustin SM, Day R, Williams CM, McAuley JH. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis. BMJ. 2021;374:n1446. PMID: 34233900; PMCID: PMC8262447. https://doi.org/10.1136/bmj.n1446
  14. Cepeda MS, Fife D, Ma Q, Ryan PB. Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study. J Pain. 2013;14(10):1227-1241. Epub 2013 Jul 10. PMID: 23850177. https://doi.org/10.1016/j.jpain.2013.05.010
  15. Subedi M, Bajaj S, Kumar MS, Yc M. An overview of tramadol and its usage in pain management and future perspective. Biomed Pharmacother. 2019;111:443-451. Epub 2018 Dec 27. PMID: 30594783. https://doi.org/10.1016/j.biopha.2018.12.085
  16. Chaparro LE, Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S, Turk DC. Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev. 2013;(8):CD004959. CD004959.pub4. PMID: 23983011. https://doi.org/10.1002/14651858
  17. Kukushkin ML, Reshetnyak VK. Purinergic mechanisms of pain and analgesia. Russian Journal of Pain. 2019;17 (1):51-56.  https://doi.org/10.25731/RASP.2019.01.09
  18. Magni G, Riccio D, Ceruti S. Tackling chronic pain and inflammation through the purinergic system. Current Medicinal Chemistry. 2018;25:32:3830-3865.
  19. Nakatsuka T, Mena N, Ling J, Gu JG. Depletion of substance P from rat primary sensory neurons by ATP, an implication of P2X receptor-mediated release of substance P. Neuroscience. 2001;107(2):293-300. 
  20. Mibielli MA, Nunes CP, Cohen JC, Scussel AB Jr, Higashi R, Bendavit GG, Oliveira L, Geller M. Treatment of acute, non-traumatic pain using a combination of diclofenac-cholestyramine, uridine triphosphate, cytidine monophosphate, and hydroxycobalamin. Proc West Pharmacol Soc. 2010;53:5-12. PMID: 22128442.
  21. Antonio Mibielli M, Pereira Nunes C, Scussel Jr A, Suchmacher Neto M, Oliveira L, Geller M. Symptomatic improvement in an acute, non-traumatic spine pain model with a combination of uridine triphosphate, cytidine monophosphate, and hydroxocobalamin. Pain Studies and Treatment. 2014;2:6-10.  https://doi.org/10.4236/pst.2014.21002
  22. Mibielli MAN, Nunes CP, Goldberg H, Buchman L, Oliveira L, Mezitis SGE, Wajnzstajn F, Kaufman R, Nigri R, Cytrynbaum N, Cunha KS, Santos A, Goldberg SW, Platenik NC, Rzetelna H, Futuro DB, Da Fonseca AS, Geller M. Nucleotides Cytidine and Uridine Associated with Vitamin B12 vs B-Complex Vitamins in the Treatment of Low Back Pain: The NUBES Study. J Pain Res. 2020;13:2531-2541. PMID: 33116795; PMCID: PMC7568635. https://doi.org/10.2147/JPR.S277024
  23. Yakupov EZ, Troshina YV, Kashapova AO, Nasrieva AM, Chizh RS. The results of an open observational study on multimodal effects of the efficacy and safety of supplement neurouridine in patients with nonspecific low back pain (MULTINEURO-1). Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2020;120(9):53-59. (In Russ.). https://doi.org/10.17116/jnevro202012009153
  24. Yakupov EZ, Troshina YV, Gainutdinova RR, Kashapova AO. The results of a study on the safety of the dietary supplement neurouridine in patients with nonspecific low back pain (MULTINEURO-2). Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(3):52-56. (In Russ.). https://doi.org/10.17116/jnevro202112103152
  25. Yakupov EZ, Troshina YV, Gainutdinova RR, Kashapova AO. Evaluation of the efficacy and safety of the neuroprotective complex Neurouridin in patients with back pain. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(6):46-51. (In Russ.). https://doi.org/10.17116/jnevro202112106146
  26. Danilov AB, Davydov OS. [Neuropathic pain epidemiology]. Pain. 2007;4(17):12-16. (In Russ.)
  27. Schaefer C, Mann R, Sadosky A, Daniel S, Parsons B, Nieshoff E, Tuchman M, Nalamachu S, Anschel A, Stacey B. Burden of Illness Associated with Peripheral and Central Neuropathic Pain among Adults Seeking Treatment in the United States: A Patient-Centered Evaluation. Pain Medicine. 2014;15(12):2105-2119.
  28. Mick G, Serpell M, Baron R, Mayoral V, Hans G, Mendez I, Artime E, Qizilbash N, Sohns M. Localised neuropathic pain in the primary care setting: a cross-sectional study of prevalence, clinical characteristics, treatment patterns, quality of life and sleep performance. Curr Med Res Opin. 2021;37(2):293-302. Epub 2020 Nov 23. Erratum in: Curr Med Res Opin. 2021 Feb 19;:1. PMID: 33140987. https://doi.org/10.1080/03007995.2020.1846174
  29. Davydov OS, Yakhno NN, Kukushkin ML, Churukanov MV, Abuzarova GR, Amelin AV, Balyazin VA, Barantsevich ER, Barinov AN, Barulin AE, Bel'skaya GN, Bykov YuN, Danilov AB, Doronina OB, Dreval' ON, Evseev MA, Zagorul'ko OI, Isagulyan ED, Kalinskiy PP, Karakulova YuV, Karateev AE, Kopenkin SS, Kurushina OV, Medvedeva LA, Parfenov VA, Sergienko DA, Strokov IA, Khabirov FA, Shirokov VA. Neuropathic pain: clinical guidelines on the diagnostics and treatment from the Russian Association for the Studying of Pain. Russian Journal of Pain. 2018;58(4):5-41.  https://doi.org/10.25731/RASP.2018.04.025
  30. Davydov OS. The neuropathic pain. How to increase the effectiveness of pharmacotherapy in real practice. Russian Journal of Pain. 2016;51(3-4):43-55. 
  31. Goldberg H, Mibielli MA, Nunes CP, Goldberg SW, Buchman L, Mezitis SG, Rzetelna H, Oliveira L, Geller M, Wajnsztajn F. A double-blind, randomized, comparative study of the use of a combination of uridine triphosphate trisodium, cytidine monophosphate disodium, and hydroxocobalamin, versus isolated treatment with hydroxocobalamin, in patients presenting with compressive neuralgias. J Pain Res. 2017;10:397-404. PMID: 28243144; PMCID: PMC5317309. https://doi.org/10.2147/JPR.S123045
  32. Nunes CP, Scussel AB Jr, Goldberg H, et al. Alcoholic Polyneuropathy: Clinical Assessment of Treatment Outcomes Following Therapy with Nucleotides and Vitamin B12», Research in Neurology: An International Journal. 2013;Article ID 208067. https://doi.org/10.5171/2013. 208067
  33. Kretschmar C, Kaumeier S, Haase W. Die medikamentöse Therapie der alkoholischen Polyneuropathie. Randomisierte Doppelblindstudie zum Vergleich zweier Vitamin-B-Präparate und eines Nukleotid-Präparates [Medicamentous therapy of alcoholic polyneuropathy. Randomized double-blind study comparing 2 vitamin B preparations and a nucleotide preparation]. Fortschr Med. 1996;114(32):439-443. German. PMID: 9064269.
  34. Gallai V, Mazzotta G, Montesi S, Sarchielli P, Del Gatto F. Effects of uridine in the treatment of diabetic neuropathy: an electrophysiological study. Acta Neurol Scand. 1992;86(1):3-7. PMID: 1325728. https://doi.org/10.1111/j.1600-0404.1992.tb08045.x
  35. Negrão L, Almeida P, Alcino S, Duro H, Libório T, Melo Silva U, Figueira R, Gonçalves S, Neto Parra L. Effect of the combination of uridine nucleotides, folic acid and vitamin B12 on the clinical expression of peripheral neuropathies. Pain Manag. 2014;4(3):191-196. Epub 2014 May 16. PMID: 24835269. https://doi.org/10.2217/pmt.14.10
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.